NORTHWEST BIOTHERAPEUTICS INC
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $14.8M | $-362.9M | $10.0M |
| FY2021 | $32.4M | $-124.0M | $15.2M |
| FY2022 | $21.5M | $-128.1M | $7.0M |
| FY2023 | $40.8M | $-65.8M | $2.1M |
| FY2024 | $62.7M | $-94.5M | $2.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $14.8M | $-362.9M | $10.0M |
| FY2021 | $32.4M | $-124.0M | $15.2M |
| FY2022 | $21.5M | $-128.1M | $7.0M |
| FY2023 | $40.8M | $-65.8M | $2.1M |
| FY2024 | $62.7M | $-94.5M | $2.2M |